Bioxel Pharma Inc.
TSX VENTURE : BIP

Bioxel Pharma Inc.

September 29, 2005 12:18 ET

Media Advisory: Bioxel Pharma to Present at BioContact Quebec 2005

SAINTE-FOY, QUEBEC--(CCNMatthews - Sept. 29, 2005) - Bioxel Pharma Inc. (TSX VENTURE:BIP), a leading manufacturer and supplier of taxane API's and developer of targeted oncology drugs, today announced that on Wednesday, October 5, 2005, its President and CEO, Mr. Pascal Delmas, will make a presentation to the BioContact Quebec 2005 Conference. This presentation will take place at 3:30 P.M., Eastern time, at the Chateau Frontenac, Place d'Armes Room.

ABOUT BIOXEL PHARMA

Bioxel Pharma Inc. is an emerging leader in biopharmaceuticals, focused on developing, manufacturing and marketing taxane pharmaceutical ingredients. Taxanes are used in drug products for the treatment of cancer and other diseases, including psoriasis, rheumatoid arthritis, Alzheimer's disease and cardiovascular disease. The Corporation sells cGMP paclitaxel and develops a portfolio of other generic taxane API's and taxane-based proprietary products for improved cancer therapy.

Contact Information